Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Androgen receptor Protein (Entity type)	Ki
Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Testicular hypogonadism Disease or Phenotype (Entity type)
Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Deficiency of testosterone biosynthesis Disease or Phenotype (Entity type)
Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Klinefelter Syndrome Disease or Phenotype (Entity type)
Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Delayed Puberty Disease or Phenotype (Entity type)
Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Steroid 17-alpha-hydroxylase/17,20 lyase Protein (Entity type)	IC50
Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Hormone receptor positive malignant neoplasm of breast Disease or Phenotype (Entity type)
Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Cryptorchidism Disease or Phenotype (Entity type)

Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Androgen receptor
Protein (Entity type)
Ki

Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Testicular hypogonadism
Disease or Phenotype (Entity type)

Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Deficiency of testosterone biosynthesis
Disease or Phenotype (Entity type)

Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Klinefelter Syndrome
Disease or Phenotype (Entity type)

Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Delayed Puberty
Disease or Phenotype (Entity type)

Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Steroid 17-alpha-hydroxylase/17,20 lyase
Protein (Entity type)
IC50

Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Hormone receptor positive malignant neoplasm of breast
Disease or Phenotype (Entity type)

Propionic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Cryptorchidism
Disease or Phenotype (Entity type)

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.